Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)

HKG:8049 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	235.85	352.14	113.6	55.29	26.02
Short-Term Investments	254.48	215.32	673.13	68.43	197.12
Trading Asset Securities	93.27	90.61	263.07	176.53	60.42
Cash & Short-Term Investments	583.59	658.06	1,050	300.26	283.55
Cash Growth	-11.32%	-37.32%	249.63%	5.89%	-67.18%
Accounts Receivable	412.91	395.36	451.02	399.61	414.61
Other Receivables	5.33	8.71	116.52	96.67	46.15
Receivables	418.23	404.06	567.54	496.28	460.76
Inventory	59.97	102.97	132.99	86.31	55
Other Current Assets	37.25	36.05	17.15	7.02	8.58
Total Current Assets	1,099	1,201	1,767	889.87	807.89
Property, Plant & Equipment	313.07	329.55	360.28	398.15	346.59
Long-Term Investments	1,049	724.16	211.41	776.49	648.52
Goodwill	6.25	6.25	6.25	6.25	-
Other Intangible Assets	0.02	0.02	0.03	0.03	-
Long-Term Deferred Tax Assets	34.32	28.51	27.4	1.51	1.51
Other Long-Term Assets	29.66	29.2	-	-	-
Total Assets	2,531	2,319	2,373	2,072	1,805
Accounts Payable	63.54	70.58	65.69	51.34	42.63
Accrued Expenses	366.62	299.85	295.28	33.78	193.37
Current Portion of Long-Term Debt	72.4	8.4	0.4	0.4	0.4
Current Income Taxes Payable	3.61	16.68	25.66	32.45	26.64
Current Unearned Revenue	22.63	16.32	24.94	16.81	8.55
Other Current Liabilities	331.87	313.45	302.63	437.03	143.84
Total Current Liabilities	860.67	725.29	714.59	571.79	415.44
Long-Term Debt	-	72	-	-	-
Long-Term Unearned Revenue	34.95	35.54	40.97	41.95	43.19
Long-Term Deferred Tax Liabilities	1.94	2.74	3.02	3.86	0.39
Other Long-Term Liabilities	3.93	2.87	1.96	0.95	-
Total Liabilities	901.49	838.44	760.54	618.56	459.02
Common Stock	56.03	56.03	56.03	56.03	56.03
Additional Paid-In Capital	51.1	51.1	51.1	51.1	-
Retained Earnings	1,522	1,373	1,505	1,347	-
Comprehensive Income & Other	-	-	-	-	1,289
Shareholders' Equity	1,630	1,480	1,612	1,454	1,345
Total Liabilities & Equity	2,531	2,319	2,373	2,072	1,805
Total Debt	72.4	80.4	0.4	0.4	0.4
Net Cash (Debt)	511.19	577.66	1,049	299.86	283.15
Net Cash Growth	-11.51%	-44.95%	249.97%	5.90%	-67.13%
Net Cash Per Share	0.91	1.03	1.87	0.54	0.51
Filing Date Shares Outstanding	560.25	560.25	560.25	560.25	560.25
Total Common Shares Outstanding	560.25	560.25	560.25	560.25	560.25
Working Capital	238.38	475.85	1,053	318.08	392.45
Book Value Per Share	2.91	2.64	2.88	2.59	2.40
Tangible Book Value	1,623	1,474	1,606	1,447	1,345
Tangible Book Value Per Share	2.90	2.63	2.87	2.58	2.40
Buildings	238.26	238.18	259.99	189.32	157.55
Machinery	273.77	262.91	252	193.29	172.29
Construction In Progress	-	4.9	-	147.86	124.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.